In fact, it is currently being discussed whether IFN-β should be neutralized during the hyper-inflammatory phase in sepsis patients due to its contribution to pro-inflammation and/or whether it needs to be supplemented while patients are in the hypo-inflammatory phase given its ability to restore and reverse immunosuppression (32). This evidence concerns the gene IFNB1 and Sepsis.